Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · IEX Real-Time Price · USD
25.92
-0.76 (-2.85%)
Jun 14, 2024, 4:00 PM EDT - Market closed

Mirum Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Net Income
-163.42-135.67-83.99-103.27-52.55
Depreciation & Amortization
11.453.680.980.620.32
Share-Based Compensation
35.0227.0123.0912.556.07
Other Operating Activities
46-15.16-72.831.026.8
Operating Cash Flow
-70.94-120.14-132.76-89.08-39.36
Capital Expenditures
-0.11-0.28107.98-0.23-0.28
Acquisitions
-212.760000
Change in Investments
125.677.98-40.4338.1-127.5
Other Investing Activities
-20--19--
Investing Cash Flow
-107.27.748.5537.87-127.78
Share Issuance / Repurchase
227.15114.649.01131.8767.2
Debt Issued / Paid
109.73-5.5564.4549.580
Other Financing Activities
-0.28---0.1659.98
Financing Cash Flow
336.6109.0973.47181.29127.18
Exchange Rate Effect
-0.130.01-00.03-0.03
Net Cash Flow
158.32-3.34-10.75130.12-39.99
Free Cash Flow
-71.05-120.41-24.78-89.3-39.64
Free Cash Flow Margin
-38.12%-156.26%-129.49%--
Free Cash Flow Per Share
-1.74-3.56-0.82-3.54-3.45
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).